Changeflow GovPing Pharma & Drug Safety Organoid Culture Compositions and Methods from ...
Routine Notice Added Final

Organoid Culture Compositions and Methods from Cryogenically Preserved Tissue

Favicon for changeflow.com USPTO Patent Grants - Biotech (C12N)
Published
Detected
Email

Summary

USPTO granted patent US12600953B2 to The Regents of the University of Michigan on April 14, 2026. The patent covers compositions and methods for establishing organoid cultures from cryogenically preserved tissue (e.g., human biopsy tissue), along with related methods of use. The application (No. 16634818) was filed on July 27, 2018, with eight claims allowed.

What changed

USPTO granted patent US12600953B2 to The Regents of the University of Michigan on April 14, 2026, establishing intellectual property rights for compositions and methods relating to organoid cultures from cryogenically preserved tissue. The patent, with inventors Jason Spence, Yu-Hwai Tsai, Michael Czerwinski, and John Kao, contains eight claims covering the organoid culture establishment techniques.

Affected parties including biotechnology companies, research institutions, and pharmaceutical firms developing organoid-based technologies should evaluate whether their products or methods may fall within the scope of these claims. Parties may wish to assess licensing opportunities or design-around strategies to avoid potential infringement.

What to do next

  1. Monitor for updates

Archived snapshot

Apr 15, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Compositions and method for establishing organoid cultures from cryogenically preserved tissue

Grant US12600953B2 Kind: B2 Apr 14, 2026

Assignee

The Regents of the University of Michigan

Inventors

Jason Spence, Yu-Hwai Tsai, Michael Czerwinski, John Kao

Abstract

The present application is directed to compositions and methods for establishing organoid cultures from cryogenically preserved tissue (e.g., human biopsy tissue), and related methods of use with such established organoid cultures.

CPC Classifications

C12N 5/0679 C12N 2501/11 C12N 2501/415 C12N 2513/00 C12N 2533/90 A01N 1/0221 A01N 1/0284

Filing Date

2018-07-27

Application No.

16634818

Claims

8

View original document →

Get daily alerts for USPTO Patent Grants - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 14th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12600953B2

Who this affects

Applies to
Pharmaceutical companies Healthcare providers Medical device makers
Industry sector
3254.1 Biotechnology
Activity scope
Patent licensing Biotechnology research Organoid development
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Patent Grants - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!